Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | AVIRAtea Pharmaceuticals, Inc.FY2021 · Dec |
|---|---|
| Revenue | $351.37M |
| Revenue, yoy | +622.5% |
| Net income | $158.35M |
| Net income, yoy | +6.0% |
| Net margin | — |
| Free cash flow | $122.93M |
| FCF margin | — |
| EPS, diluted | $1.94 |
Add another company.